Focused on accelerating the development of new medicines.
Translating the potential of a plant-based approach and production system to develop new biological medicines to meet high unmet patient needs worldwide.
Seeking opportunities to accelerate the development of treatments for rare and infectious diseases
KBio is focusing on delivering value for patients from its existing antibody and vaccine clinical pipeline in rare and infectious diseases and will seek opportunities to form innovative R&D collaborations and financing, with the aim of expanding its pipeline of potential new medicines.